AAO 2023: Latest on the Atia Vision IOL device

Mariam Maghribi, Chief Business Officer for Shifamed, spoke with Ophthalmology Times about the Atia Vision IOL device at this year's American Academy of Ophthalmology meeting.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Mariam Maghribi:

Hello, my name is Mariam Maghribi. I'm the Chief Business Officer for Shifamed. I'm also the CEO for Atia Vision. I'm happy to be at the 2023 AAO meeting. I was also happy to participate on a panel at the eyecelerator, and we also had our data being presented this morning by Dr. Daniel Chang, our 12 month first in human data. We're excited about what we're seeing with our accommodating IOL. It's showing very promising early data, and we're happy to share that now with the world.

Let me tell you a little bit about the Atia Vision device. It's a modular, two-piece, accommodating lens, we've got a base that accommodates, as well as the front optic that really gives you the stable refractions. Atia Vision is part of a larger innovation hub located in Silicon Valley. Shifamed, basically provides turnkey solutions to the strategics. Where we're trying to bring innovations to the market by derisking on the technical manufacturing as well as the clinical set, and then partnering with the larger strategics to take it to the larger FDA studies as well as commercialization.